
|Videos|January 30, 2023
Determining Which Patients With Multiple Myeloma are Candidates for Triplet Combination Therapies
Author(s)Joshua Richter, MD, Srdan Verstovsek, MD, PhD
Dr Joshua Richter explains which patients with multiple myeloma are most suitable for triplet combination therapies.
Advertisement
Episodes in this series

Advertisement
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
Gedatolisib Improves PFS in HR+/HER2-/PIK3CA-WT Advanced Breast Cancer
2
Nadunolimab Misses Efficacy Mark in TNBC, Despite Strong OS
3
FDA Approves Niraparib/Abiraterone Combo for BRCA2-Mutated mCSPC
4
Real-World Pola-R-CHP vs R-CHOP Effectiveness in Older DLBCL Patients
5










































